Tension-free vaginal tape for primary genuine stress incontinence: a two-centre follow-up study.
OBJECTIVE
To assess the safety and efficacy of the tension-free vaginal tape procedure in the treatment of primary genuine stress incontinence.


METHODS
A two-centre follow-up study was conducted on 40 women with urodynamically confirmed primary genuine stress incontinence who had a tension-free vaginal tape inserted under local anaesthesia with sedation. Operative details were recorded and all patients followed up both subjectively, and objectively with repeat urodynamic studies and pad testing.


RESULTS
The mean (range) age of the women was 51.1 (33-86) years, the median parity 2 (0-4) and mean body mass index 25.1 (19-35). The mean anaesthesia and operative duration was 42 (25-65) min; 93% of the women resumed immediate spontaneous voiding with no need for catheterization. The mean inpatient stay was 2.2 (2-4) days (where 2 days is equivalent to one night in hospital). The follow-up was conducted at a mean interval of 12.3 (6-24) months. Subjectively, 80% of women were cured and 17.5% significantly improved; objectively, genuine stress incontinence was cured in 95%. Symptomatic postoperative detrusor instability was found in 15% of women and symptoms of voiding dysfunction identified in 5% of women. There were no defects in healing or tape rejection.


CONCLUSIONS
The tension-free vaginal tape procedure is a promising new technique that, in this short-term analysis, appears to be safe and effective. Intra-operative complications are uncommon and both hospital stay and recovery are short. Voiding complications are rare but symptomatic postoperative detrusor instability had an incidence of 15%.
Moran
P A
PA
Department of Obstetrics and Gynaecology, Northampton General Hospital, UK. moranpa@doctors.org.uk
Ward
K L
KL
Johnson
D
D
Smirni
W E
WE
Hilton
P
P
Bibby
J
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D011126:Polypropylenes / Q000627:therapeutic use*; D019736:Prostheses and Implants; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000601:surgery*; D014563:Urodynamics
D011126:Polypropylenes